Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha

被引：38

作者：

Bacher, U

Hochhaus, A

Berger, U

Hiddemann, W

Hehlmann, R

Haferlach, T

Schoch, C

机构：

[1] Univ Munich, Klinikum Grosshadern, Lab Leukemia Diagnost, Dept Internal Med 3, D-81377 Munich, Germany

[2] Fakultar Klin Med Mannheim Univ, Med Klin 3, Heidelberg, Germany

来源：

LEUKEMIA | 2005年 / 19卷 / 03期

关键词：

D O I：

10.1038/sj.leu.2403607

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：460 / 463

页数：5

共 8 条

[1] CLONAL ORIGIN OF PHILADELPHIA-CHROMOSOME NEGATIVE CELLS WITH TRISOMY-8 APPEARING DURING THE COURSE OF ALPHA-INTERFERON THERAPY FOR PH POSITIVE CHRONIC MYELOCYTIC-LEUKEMIA [J].

ARIYAMA, T ;

INAZAWA, J ;

UEMURA, Y ;

KAKAZU, N ;

MAEKAWA, T ;

URASE, F ;

IRIMAJIRI, K ;

HORIUCHI, A ;

NAKAMURA, Y ;

ABE, T .

CANCER GENETICS AND CYTOGENETICS, 1995, 81 (01) :20-23

[2] Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority [J].

Bumm, T ;

Müller, C ;

Al-Ali, HK ;

Krohn, K ;

Shepherd, P ;

Schmidt, E ;

Leiblein, S ;

Franke, C ;

Hennig, E ;

Friedrich, T ;

Krahl, R ;

Niederwieser, D ;

Deininger, MWN .

BLOOD, 2003, 101 (05) :1941-1949

[3] Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase [J].

Medina, J ;

Kantarjian, H ;

Talpaz, M ;

O'Brien, S ;

Garcia-Manero, G ;

Giles, F ;

Rios, MB ;

Hayes, K ;

Cortes, J .

CANCER, 2003, 98 (09) :1905-1911

[4] Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with imatinib [J].

Meeus, P ;

Demuynck, H ;

Martiat, P ;

Michaux, L ;

Wouters, E ;

Hagemeijer, A .

LEUKEMIA, 2003, 17 (02) :465-467

[5] Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate [J].

O'Dwyer, ME ;

Gatter, KM ;

Loriaux, M ;

Druker, BJ ;

Olson, SB ;

Magenis, RE ;

Lawce, H ;

Mauro, MJ ;

Maziarz, RT ;

Braziel, RM .

LEUKEMIA, 2003, 17 (03) :481-487

[6] Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate [J].

Schoch, C ;

Haferlach, T ;

Kern, W ;

Schnittger, S ;

Berger, U ;

Hehlmann, R ;

Hiddemann, W ;

Hochhaus, A .

LEUKEMIA, 2003, 17 (02) :461-463

[7] Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases [J].

Schoch, C ;

Schnittger, S ;

Bursch, S ;

Gerstner, D ;

Hochhaus, A ;

Berger, U ;

Hehlmann, R ;

Hiddemann, W ;

Haferlach, T .

LEUKEMIA, 2002, 16 (01) :53-59

[8] Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia [J].

Terre, C ;

Eclache, V ;

Rousselot, P ;

Imbert, M ;

Charrin, C ;

Gervais, C ;

Mozziconacci, MJ ;

Maarek, O ;

Mossafa, H ;

Auger, N ;

Dastugue, N ;

Talmant, P ;

Van den Akker, J ;

Leonard, C ;

Khac, FN ;

Mugneret, F ;

Viguié, F ;

Lafage-Pochitaloff, M ;

Bastie, JN ;

Roux, GL ;

Nicolini, F ;

Maloisel, F ;

Vey, N ;

Laurent, G ;

Recher, C ;

Vigier, M ;

Yacouben, Y ;

Giraudier, S ;

Vernant, JP ;

Salles, B ;

Roussi, J ;

Castaigne, S ;

Leymarie, V ;

Flandrin, G ;

Lessard, M .

LEUKEMIA, 2004, 18 (08) :1340-1346

← 1 →